electroCore,

electroCore, Net Debt

The Net Debt of electroCore, (ECOR) as of Oct 18, 2026 is -2.21 M USD. In the previous year, Net Debt was -7.83 M USD — a change of -71.81% (higher).

Net Debt

-2.21 MUSD

YoY

-71.81%

Last updated:

Net Debt of electroCore, is 2025 -2.21 M USD. Net Debt of electroCore, was 2024 -7.83 M USD. It decreases by -71.81% higher compared to the previous year.

The electroCore, Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2016
6.92 M USD
Jan 1, 2019
-22.04 M USD
Jan 1, 2020
-19.80 M USD
Jan 1, 2021
-33.93 M USD
Jan 1, 2022
-17.01 M USD
Jan 1, 2023
-9.71 M USD
Jan 1, 2024
-7.83 M USD
Jan 1, 2025
-2.21 M USD
The electroCore, Net Debt history
YEARNet DebtYoY
-2.21 MUSD-71.81%
-7.83 MUSD-19.29%
-9.71 MUSD-42.96%
-17.01 MUSD-49.86%
-33.93 MUSD+71.36%
-19.80 MUSD-10.17%
-22.04 MUSD-418.71%
6.92 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Net Debt of electroCore, is -2.21 M USD in 2025.

Net Debt of electroCore, changed from -7.83 M USD to -2.21 M USD, representing a -71.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt electroCore, since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — electroCore,

All Key Metrics — electroCore,